Case Reports
Penicillamine-induced ocular myasthenia gravis in rheumatoid arthritis
Affiliations
- PMID: 2144538
Item in Clipboard
Case Reports
Penicillamine-induced ocular myasthenia gravis in rheumatoid arthritis
J Clin Neuroophthalmol.
1990 Sep.
Abstract
We report a case of a 47-year-old woman with rheumatoid arthritis who developed ocular myasthenia gravis during penicillamine treatment. Her serum contained elevated titers of acetylcholine receptor antibodies, and her symptoms resolved 8 weeks after discontinuation of penicillamine. We review the clinical and laboratory features of this syndrome of penicillamine-induced myasthenia gravis and discuss its pathophysiology and treatment.
Similar articles
-
[D-penicillamine-induced myasthenia gravis].Schweiz Med Wochenschr. 1994 May 21;124(20):852-6. Schweiz Med Wochenschr. 1994. PMID: 8209208 German.
-
D-penicillamine and the ocular myasthenic syndrome.Ann Ophthalmol. 1981 Oct;13(10):1171-2. Ann Ophthalmol. 1981. PMID: 7316342
-
[Myasthenia gravis syndrome following administration of d-penicillamine (author's transl)].Acta Neurol Belg. 1980 May-Jun;80(3):165-73. Acta Neurol Belg. 1980. PMID: 7457085 French.
-
[D-penicillamine induced myasthenia gravis in a patient with rheumatoid arthritis].Ryumachi. 1991 Jun;31(3):298-302; discussion 302-3. Ryumachi. 1991. PMID: 1948449 Review. Japanese.
-
Ocular myasthenia gravis after D-penicillamine administration.Br J Ophthalmol. 1989 Dec;73(12):1015-8. doi: 10.1136/bjo.73.12.1015. Br J Ophthalmol. 1989. PMID: 2692700 Free PMC article. Review.
Cited by
-
Drugs That Induce or Cause Deterioration of Myasthenia Gravis: An Update.J Clin Med. 2021 Apr 6;10(7):1537. doi: 10.3390/jcm10071537. J Clin Med. 2021. PMID: 33917535 Free PMC article. Review.
-
Clinically important ocular reactions to systemic drug therapy.Drug Saf. 1993 Sep;9(3):196-211. doi: 10.2165/00002018-199309030-00005. Drug Saf. 1993. PMID: 8240725 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical